Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Dr. Lal PathLabs Limited
LALPATHLAB | NSE
1,408.90
INR-22.00
-1.54%
LALPATHLAB | NSE
Loading StockChartView...
About Dr. Lal PathLabs Limited
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
31/03/2024
As of date
24/04/2026
Close
1,408.90
Open
1,435.50
High
1,435.50
Low
1,399.90
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry hematology histopathology microbiology electrophoresis immuno-chemistry immunology virology cytology and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31 2022 the company had 277 clinical laboratories including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4731 patient service centers and 10599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram India.
View LessLALPATHLAB | NSE
Risk
27.0
Sharpe
-0.10
Luna's Score
58/100
Recommendation
Hold
Luna says (LALPATHLAB | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
32.0%1 month
27.0%3 months
23.6%6 months
23.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
72.99
Fwd. PE
50.25
Price to book
14.92
Debt to equity
0.13
Debt to assets
0.10
Ent. to EBITDA
37.97
Ent. to rev.
11.76
PEG
-
Other Fundamentals
EBITDA
5.91B
MarketCap
117.36B
MarketCap(USD)
1.23B
Div. yield
0.36
Op. margin
22.48
Erngs. growth
28.50
Rev. growth
11.30
Ret. on equity
20.21
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
106.00
Range1M
186.50
Range3M
201.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.93
Price X volume
457.34M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 37.97 | 22.78 | Expensive |
| Ent. to Revenue | 11.76 | 6.55 | Expensive |
| PE Ratio | 72.99 | 51.14 | Expensive |
| Price to Book | 14.92 | 6.69 | Expensive |
| Dividend Yield | 0.36 | 0.94 | Poor |
| Std. Deviation (3M) | 23.64 | 32.84 | Lower Risk |
| Debt to Equity | 0.13 | 0.18 | Cheaper |
| Debt to Assets | 0.10 | 0.12 | Par |
| Market Cap | 117.36B | 60.74B | Market Leader |
